Osmol Therapeutics

New Haven, United States

Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.

$5.2M raised

Apr 2022

Series A

Health Care Pharmaceutical Therapeutics

Top Investors

Koax Investment Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Osmol Therapeutics

How much funding has Osmol Therapeutics raised?

Osmol Therapeutics has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Who are Osmol Therapeutics's investors?

Osmol Therapeutics's investors include Koax Investment Partners.

Where is Osmol Therapeutics headquartered?

Osmol Therapeutics is headquartered in New Haven, United States.

What does Osmol Therapeutics do?

Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.

What stage is Osmol Therapeutics at?

Osmol Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 12, 2022.

MLA

"Osmol Therapeutics — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/osmol-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Osmol Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/osmol-therapeutics

Wikipedia (cite web)

{{cite web |title=Osmol Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/osmol-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 12, 2022.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K